Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Affect Disord. 2018 Dec 24;246:716–726. doi: 10.1016/j.jad.2018.12.068

Table 2.

Clinical Data in Participants with Bipolar Disorder I (BD-I), Bipolar Disorder Not Otherwise Specified (BD-NOS), and Healthy Controls (HC)

BD-I Participants (n=28) BD-NOS Participants (n=14) HC (n=52) Statistic
Symptom Measuresa Mean SD Mean SD Mean SD
Young Mania Rating Scale 4.18 3.41 3.43 2.03 -- -- t=0.76, df=40, p=0.454
Hamilton Depression Rating Scale 4.32 3.93 4.50 5.93 -- -- t =-0.12, df=40, p=0.908
Hamilton Anxiety Rating Scale 6.50 4.85 5.43 6.10 -- -- t=0.62, df=40, p=0.539
Global Assessment of Functioningb 66.36 13.13 70.11 12.30 90.02c 5.42 F=64.04, df=2, 89 p=0.000
Current Comorbid SCID diagnoses
N % N % N %
Attention deficit/hyperactivity disorder 17 60.7 7 50.0 --
Generalized anxiety disorder 4 14.3 2 14.3 --
Panic Disorder 4 14.3 3 21.4 --
Social Phobia 0 0 0 0 --
PTSD 1 3.6 0 0 --
Substance Abuse History 6 21.4 2 14.3
Mood State
Euthymicc 22 78.6 12 85.7 --
Depressedd 5 17.9 2 14.3 --
Hypomanice 1 3.6 -- -- --
Medications at MRI
No medications 14 50.0 9 64.3
Mood Stabilizer 1 3.6 0f 0 --
Antiepileptic 6 21.4 2f 14.3
Antipsychotic 1 3.6 0f 0
Atypical antipsychotic 1 3.6 1f 7.1 --
SSRI 2 7.1 2f 14.3
Other Antidepressant 2 7.1 1f 7.1
Stimulant medications 9 32.1 1f 7.1 --
Sedative 0 0 0f 0
a

In majority of cases, symptom assessment occurred on the day of the MRI. When that score was not available, we replaced it with one from within one month for patients (1/42 total), and for the HC GAF, with their baseline visit GAF score (7/52 total).

b

Based on the post-hoc Games-Howell test, there were significant mean differences between BD-I and HC (p < 0.000, d=2.4), and BD-NOS and HC (p < 0.000, d=2.1).

c

Defined as YMRS ≤ 12 and HAM-D ≤7.

d

Defined as YMRS ≤12 and HAM-D ≥8.

e

Defined as YMRS 13–26 and HAM-D ≤7.

f

1 report missing within the group.